While Pfizer posted disappointing third-quarter results last month, it also, like peer Merck, offered upbeat guidance. Pfizer shares ended the final two weeks of October about 5% higher than where they started, again boosted by the earnings report. Meanwhile, the Dow rose only fractionally by the settlement date.
Shares closed most recently at $36.93 apiece, which is down more than 2% in the past week. Pfizer’s 52-week low of $33.97 was seen in August, and the 52-week high of $46.47 was from last December. The stock now trades more than 14% lower than at the beginning of the year.
And the Rest
Rounding out the top five most shorted Dow stocks on the most recent settlement date were Apple Inc. (NASDAQ: AAPL) and Exxon Mobil Corp. (NYSE: XOM). Only the latter saw a gain in the number of its shares short during the final two weeks of October. The share price of Apple rose during the period, more than 6%, buoyed by a strong showing for its fiscal fourth quarter. On the other hand, Exxon shares retreated marginally during those two weeks, even though its latest earnings decline was not as bad as expected.
Also notice on the following list of short interest changes in Dow stocks as of October 31 the double-digit rise at Cisco (ex-CEO launches cloud startup), JPMorgan (trade concerns) and Caterpillar (earnings miss).
|Dow Stock||Short (millions)||Change||% Float|
|Procter & Gamble||22.82||2.61%||0.92%|
|Johnson & Johnson||16.95||1.37%||0.64%|